Symbicort (Budesonide/Formoterol) for asthma

Overview
Symbicort is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of asthma in people age 6 or older. Symbicort helps prevent bronchospasm. Symbicort is not indicated for rescue usage during acute bronchospasms.

Symbicort is a combination drug containing both Budesonide and Formoterol. Budesonide is a glucocorticoid steroid, a drug that suppresses the immune system. Budesonide is believed to work by reducing inflammation in the lungs, lowering the risk of bronchospasm. Formoterol is a long-acting bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Formoterol is believed to work by relaxing smooth muscles in the airways.

How do I take it?
Symbicort is inhaled orally twice a day.
Symbicort comes in an aerosol inhaler.

Side effects
The FDA-approved label for Symbicort lists common side effects including runny nose, headache, back pain, stomach pain, vomiting, throat pain, influenza, and oral yeast infection.

Rare but serious side effects listed for Symbicort include worsening asthma symptoms, worsening of infections, glaucoma, decreased bone density, hypersensitivity reactions, and paradoxical bronchospasm (bronchospasm caused by taking medication).

For more details about this treatment, visit:
Symbicort – AstraZeneca
https://www.mysymbicort.com/